MOBISTA

Serial Number 90262583
606

Registration Progress

Application Filed
Oct 19, 2020
Under Examination
Jun 22, 2021
Approved for Publication
Apr 27, 2021
Published for Opposition
Apr 27, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: MOBISTA
Previous Owner: Celldex Therapeutics, Inc.
Classes: 005

Trademark Image

MOBISTA

Basic Information

Serial Number
90262583
Filing Date
October 19, 2020
Published for Opposition
April 27, 2021
Abandonment Date
July 29, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 29, 2024
Classes
005

Rights Holder

Celldex Therapeutics, Inc.

03
Address
53 Frontage Road, Suite 220
Hampton, NJ 08827

Ownership History

Celldex Therapeutics, Inc.

Original Applicant
03
Hampton, NJ

Celldex Therapeutics, Inc.

Owner at Publication
03
Hampton, NJ

Legal Representation

Attorney
Vanessa A. Ignacio, Esq.

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

31 events
Date Code Type Description Documents
Jul 29, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 29, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 11, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 1, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 11, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 25, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 25, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
May 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 1, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 29, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 29, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 21, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 21, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 7, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 3, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 3, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 3, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 22, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 27, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 27, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 7, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 19, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 6, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 22, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of human diseases and medical conditions, namely, cancer, infections, infectious diseases, inflammatory disorders, immune system disorders, autoimmune disorders and transplant rejection; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors for stem cells in stem cell mobilization, immune system stimulators and immune system modulators; Diagnostic agents, preparations and substances for medical purposes

Classification

International Classes
005